Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Passive Income Stocks to Buy Right Now. Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD On November 12, Scotiabank analyst Louise Chen began coverage on ten large-cap biopharma companies and shared an “out-of-consensus” positive view on the sector, according to a report by The Fly. She pointed out that years of underperformance in large cap biopharma stocks, compared with other sectors a ...